Home Office squanders billions on asylum hotels, leading to community unrest and excess profits for private providers, as a damning report reveals failures of leadership and oversight.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
Home Office squanders billions on asylum hotels, leading to community unrest and excess profits for private providers, as a damning report reveals failures of leadership and oversight.
Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.